Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 1
1981 1
1982 3
1983 7
1984 12
1985 13
1986 13
1987 13
1988 15
1989 23
1990 21
1991 23
1992 32
1993 42
1994 48
1995 60
1996 66
1997 70
1998 89
1999 92
2000 111
2001 103
2002 139
2003 166
2004 204
2005 274
2006 357
2007 406
2008 499
2009 650
2010 704
2011 903
2012 1076
2013 1254
2014 1487
2015 1685
2016 1822
2017 1902
2018 2180
2019 2416
2020 2874
2021 3364
2022 3936
2023 3802
2024 3049
2025 3

Text availability

Article attribute

Article type

Publication date

Search Results

32,239 results

Results by year

Filters applied: . Clear all
Page 1
Legumain in cardiovascular diseases.
Zhou L, Wu J, Wei Z, Zheng Y. Zhou L, et al. Exp Biol Med (Maywood). 2024 Jul 22;249:10121. doi: 10.3389/ebm.2024.10121. eCollection 2024. Exp Biol Med (Maywood). 2024. PMID: 39104790 Free PMC article. Review.
New Secondary Metabolites of Mangrove-Associated Strains.
Yu Y, Wang Z, Xiong D, Zhou L, Kong F, Wang Q. Yu Y, et al. Among authors: zhou l. Mar Drugs. 2024 Aug 16;22(8):372. doi: 10.3390/md22080372. Mar Drugs. 2024. PMID: 39195488 Free PMC article. Review.
World-wide-working-web: How to be successful on global teams.
Yanez Arteta M, Zhou L, Tehler U, Bak A. Yanez Arteta M, et al. Among authors: zhou l. J Pharm Sci. 2024 Aug 22:S0022-3549(24)00317-4. doi: 10.1016/j.xphs.2024.08.014. Online ahead of print. J Pharm Sci. 2024. PMID: 39179031 Review.
A predictive model for therapy failure in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor therapy.
Zhang X, Liu B, Huang J, Zhang YL, Xu N, Gale RP, Li W, Liu X, Zhu H, Pan L, Yang Y, Lin H, Du X, Liang R, Chen C, Wang X, Li G, Liu Z, Zhang Y, Liu Z, Hu J, Liu C, Li F, Yang W, Meng L, Han Y, Lin L, Zhao Z, Tu C, Zheng C, Bai Y, Zhou Z, Chen S, Qiu H, Yang L, Sun X, Sun H, Zhou L, Liu Z, Wang D, Guo J, Pang L, Zeng Q, Suo X, Zhang W, Zheng Y, Huang X, Jiang Q. Zhang X, et al. Among authors: zhou l. Blood. 2024 Jul 24:blood.2024024761. doi: 10.1182/blood.2024024761. Online ahead of print. Blood. 2024. PMID: 39046786
32,239 results
You have reached the last available page of results. Please see the User Guide for more information.